SQI Diagnostics Inc (SQD) - Medical Equipment - Deals and Alliances Profile
- GDME2237D
- Pages: 58
- November 2018
- Total Views:1296
- Region : North America
- GlobalData
- Equity Research Report
Details
Summary
SQI Diagnostics Inc (SQI Diagnostics) is a diagnostic company that provides in vitro diagnostic and pharmaceutical research products. The company provides products such as sqidworks, sqidlite and sqid-X. Its sqidworks system is used in labs. SQI Diagnostic's sqidlite is a practical benchtop system. It provides products for immunogenicity and bioanalysis, IVD and clinical, biomarkers and assay development applications, among others. SQI Diagnostic's technologies are used in antigens, anti-drug antibodies and dual-layer multiplexing, among others. The company provides solutions to the testing needs of three markets such as pharmaceutical and biotechnology drug development, human diagnostic testing and animal health diagnostic testing, among others. SQI Diagnostics is headquartered in Toronto, Ontario, Canada.
SQI Diagnostics Inc (SQD)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
SQI Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
SQI Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
SQI Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
SQI Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
SQI Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
SQI Diagnostics Inc, Medical Equipment, Deal Details 11
Partnerships 11
SQI Diagnostics Enters into Licensing Agreement with McMaster University 11
SQI Diagnostics Enters into Agreement with A Pharma Company for Assay Development and Sample Testing Services 12
SQI Diagnostics Enters into Partnership 13
SQI Diagnostics Enters into Co-Development Agreement 14
SQI Diagnostics Expands Co-development Agreement With Pharma Company To Develop Multiplexed Test 15
SQI Diagnostics Enters Into Agreement With US-Based Pharma Company For Antibody Assay 16
SQI Diagnostics Enters Into Agreement With Algorithme Pharma To Develop Multiplex Heparin Immunogenicity Assay 17
SQI Diagnostics Enters Into Distribution Agreement With Integrated Sciences 18
Equity Offering 19
SQI Diagnostics Raises USD2.7 Million in Private Placement of Units 19
SQI Diagnostics Raises USD3.6 Million in Private Placement of Units 20
SQI Diagnostics Raises USD2.7 Million in Private Placement of Units 21
SQI Diagnostics Raises USD2.4 Million in Rights Offering of Shares 22
SQI Diagnostics Raises Additional Funds in Private Placement of Units 23
SQI Diagnostics Raises USD2.2 Million in Private Placement of Shares 24
SQI Diagnostics Raises USD2.2 Million in First Tranche of Private Placement of Shares 25
SQI Diagnostics Completes Public Offering Of Units For USD 3.8 Million 26
SQI Diagnostics Completes Private Placement Of Units For USD 1.3 Million 27
SQI Diagnostics Completes Private Placement Of Units For USD 4 Million 28
Sqi Diagnostics Completed Final Tranche Of Private Placement Of Units For Additional USD 0.5 Million 29
Debt Offering 31
SQI Diagnostics Completes Second and Final Tranche of Private Placement of Debentures for USD1.3 Million 31
Asset Transactions 32
SQI Diagnostics Sells Sqid-X system to IRX Therapeutics 32
Acquisition 33
SQI Diagnostics Plans For Sale Of The Company 33
SQI Diagnostics Inc-Key Competitors 34
SQI Diagnostics Inc-Key Employees 35
SQI Diagnostics Inc-Locations And Subsidiaries 36
Head Office 36
Recent Developments 37
Financial Announcements 37
Aug 16, 2018: SQI Diagnostics announces third quarter 2018 results 37
May 10, 2018: SQI Diagnostics Reports Second Quarter 2018 Results 39
Feb 05, 2018: SQI Diagnostics Reports First Quarter 2018 Results 41
Nov 16, 2017: SQI Diagnostics Reports Fourth Quarter and Fiscal 2017 Results 43
Aug 24, 2017: SQI Diagnostics Reports Third Quarter 2017 Results 45
May 10, 2017: SQI Diagnostics Reports Second Quarter 2017 Results 47
Feb 21, 2017: SQI Diagnostics Reports First Quarter 2017 Results 49
Corporate Communications 50
Jun 13, 2018: SQI Diagnostics Names Eric Zwisler As Board Director 50
Sep 27, 2017: SQI Diagnostics Announces Dr. Eric Brouwer Joins SQI as Chief Scientific Officer 51
Jul 13, 2017: Dr. Jaymie Sawyer, Vice President of R&D, Transitions to Lead Scientific Advisory Committee 52
Jan 18, 2017: SQI Diagnostics Announces Change to its Board of Directors 53
Other Significant Developments 54
Jul 30, 2018: SQI Diagnostics gains momentum achieving recurring revenues with major new commercial milestones 54
May 10, 2018: SQI Diagnostics and Microdrop Launch Revolutionary Disease Awareness Tests for Direct-to-Consumer Market. 56
Jan 17, 2018: SQI Signs Agreement with a Global Biotechnology Company 57
Appendix 58
Methodology 58
About GlobalData 58
Contact Us 58
Disclaimer 58
List Of Figure
List of Figures
SQI Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
SQI Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
SQI Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
SQI Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
SQI Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
SQI Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
SQI Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
SQI Diagnostics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9
List Of Table
List of Tables
SQI Diagnostics Inc, Medical Equipment, Key Facts, 2017 2
SQI Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
SQI Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
SQI Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
SQI Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
SQI Diagnostics Inc, Deals By Market, 2012 to YTD 2018 9
SQI Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
SQI Diagnostics Enters into Licensing Agreement with McMaster University 11
SQI Diagnostics Enters into Agreement with A Pharma Company for Assay Development and Sample Testing Services 12
SQI Diagnostics Enters into Partnership 13
SQI Diagnostics Enters into Co-Development Agreement 14
SQI Diagnostics Expands Co-development Agreement With Pharma Company To Develop Multiplexed Test 15
SQI Diagnostics Enters Into Agreement With US-Based Pharma Company For Antibody Assay 16
SQI Diagnostics Enters Into Agreement With Algorithme Pharma To Develop Multiplex Heparin Immunogenicity Assay 17
SQI Diagnostics Enters Into Distribution Agreement With Integrated Sciences 18
SQI Diagnostics Raises USD2.7 Million in Private Placement of Units 19
SQI Diagnostics Raises USD3.6 Million in Private Placement of Units 20
SQI Diagnostics Raises USD2.7 Million in Private Placement of Units 21
SQI Diagnostics Raises USD2.4 Million in Rights Offering of Shares 22
SQI Diagnostics Raises Additional Funds in Private Placement of Units 23
SQI Diagnostics Raises USD2.2 Million in Private Placement of Shares 24
SQI Diagnostics Raises USD2.2 Million in First Tranche of Private Placement of Shares 25
SQI Diagnostics Completes Public Offering Of Units For USD 3.8 Million 26
SQI Diagnostics Completes Private Placement Of Units For USD 1.3 Million 27
SQI Diagnostics Completes Private Placement Of Units For USD 4 Million 28
Sqi Diagnostics Completed Final Tranche Of Private Placement Of Units For Additional USD 0.5 Million 29
SQI Diagnostics Completes Second and Final Tranche of Private Placement of Debentures for USD1.3 Million 31
SQI Diagnostics Sells Sqid-X system to IRX Therapeutics 32
SQI Diagnostics Plans For Sale Of The Company 33
SQI Diagnostics Inc, Key Competitors 34
SQI Diagnostics Inc, Key Employees 35
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
SQI Diagnostics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
SQI Diagnostics Inc (SQI Diagnostics) is a diagnostic company that provides in vitro diagnostic and pharmaceutical research products. The company provides products such as sqidworks, sqidlite and sqid-X. Its sqidworks system is used in labs. SQI Diagnostic's sqidlite is a practical benchtop system. It provides products for immunogenicity and bioanalysis, IVD and clinical, biomarkers and assay development applications, among others. SQI Diagnostic's technologies are used in antigens, anti-drug antibodies and dual-layer multiplexing, among others. The company provides solutions to the testing needs of three markets such as pharmaceutical and biotechnology drug development, human diagnostic testing and animal health diagnostic testing, among others. SQI Diagnostics is headquartered in Toronto, Ontario, Canada.
SQI Diagnostics Inc (SQD)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
SQI Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
SQI Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
SQI Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
SQI Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
SQI Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
SQI Diagnostics Inc, Medical Equipment, Deal Details 11
Partnerships 11
SQI Diagnostics Enters into Licensing Agreement with McMaster University 11
SQI Diagnostics Enters into Agreement with A Pharma Company for Assay Development and Sample Testing Services 12
SQI Diagnostics Enters into Partnership 13
SQI Diagnostics Enters into Co-Development Agreement 14
SQI Diagnostics Expands Co-development Agreement With Pharma Company To Develop Multiplexed Test 15
SQI Diagnostics Enters Into Agreement With US-Based Pharma Company For Antibody Assay 16
SQI Diagnostics Enters Into Agreement With Algorithme Pharma To Develop Multiplex Heparin Immunogenicity Assay 17
SQI Diagnostics Enters Into Distribution Agreement With Integrated Sciences 18
Equity Offering 19
SQI Diagnostics Raises USD2.7 Million in Private Placement of Units 19
SQI Diagnostics Raises USD3.6 Million in Private Placement of Units 20
SQI Diagnostics Raises USD2.7 Million in Private Placement of Units 21
SQI Diagnostics Raises USD2.4 Million in Rights Offering of Shares 22
SQI Diagnostics Raises Additional Funds in Private Placement of Units 23
SQI Diagnostics Raises USD2.2 Million in Private Placement of Shares 24
SQI Diagnostics Raises USD2.2 Million in First Tranche of Private Placement of Shares 25
SQI Diagnostics Completes Public Offering Of Units For USD 3.8 Million 26
SQI Diagnostics Completes Private Placement Of Units For USD 1.3 Million 27
SQI Diagnostics Completes Private Placement Of Units For USD 4 Million 28
Sqi Diagnostics Completed Final Tranche Of Private Placement Of Units For Additional USD 0.5 Million 29
Debt Offering 31
SQI Diagnostics Completes Second and Final Tranche of Private Placement of Debentures for USD1.3 Million 31
Asset Transactions 32
SQI Diagnostics Sells Sqid-X system to IRX Therapeutics 32
Acquisition 33
SQI Diagnostics Plans For Sale Of The Company 33
SQI Diagnostics Inc-Key Competitors 34
SQI Diagnostics Inc-Key Employees 35
SQI Diagnostics Inc-Locations And Subsidiaries 36
Head Office 36
Recent Developments 37
Financial Announcements 37
Aug 16, 2018: SQI Diagnostics announces third quarter 2018 results 37
May 10, 2018: SQI Diagnostics Reports Second Quarter 2018 Results 39
Feb 05, 2018: SQI Diagnostics Reports First Quarter 2018 Results 41
Nov 16, 2017: SQI Diagnostics Reports Fourth Quarter and Fiscal 2017 Results 43
Aug 24, 2017: SQI Diagnostics Reports Third Quarter 2017 Results 45
May 10, 2017: SQI Diagnostics Reports Second Quarter 2017 Results 47
Feb 21, 2017: SQI Diagnostics Reports First Quarter 2017 Results 49
Corporate Communications 50
Jun 13, 2018: SQI Diagnostics Names Eric Zwisler As Board Director 50
Sep 27, 2017: SQI Diagnostics Announces Dr. Eric Brouwer Joins SQI as Chief Scientific Officer 51
Jul 13, 2017: Dr. Jaymie Sawyer, Vice President of R&D, Transitions to Lead Scientific Advisory Committee 52
Jan 18, 2017: SQI Diagnostics Announces Change to its Board of Directors 53
Other Significant Developments 54
Jul 30, 2018: SQI Diagnostics gains momentum achieving recurring revenues with major new commercial milestones 54
May 10, 2018: SQI Diagnostics and Microdrop Launch Revolutionary Disease Awareness Tests for Direct-to-Consumer Market. 56
Jan 17, 2018: SQI Signs Agreement with a Global Biotechnology Company 57
Appendix 58
Methodology 58
About GlobalData 58
Contact Us 58
Disclaimer 58
List Of Figure
List of Figures
SQI Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
SQI Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
SQI Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
SQI Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
SQI Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
SQI Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
SQI Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
SQI Diagnostics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9
List Of Table
List of Tables
SQI Diagnostics Inc, Medical Equipment, Key Facts, 2017 2
SQI Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
SQI Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
SQI Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
SQI Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
SQI Diagnostics Inc, Deals By Market, 2012 to YTD 2018 9
SQI Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
SQI Diagnostics Enters into Licensing Agreement with McMaster University 11
SQI Diagnostics Enters into Agreement with A Pharma Company for Assay Development and Sample Testing Services 12
SQI Diagnostics Enters into Partnership 13
SQI Diagnostics Enters into Co-Development Agreement 14
SQI Diagnostics Expands Co-development Agreement With Pharma Company To Develop Multiplexed Test 15
SQI Diagnostics Enters Into Agreement With US-Based Pharma Company For Antibody Assay 16
SQI Diagnostics Enters Into Agreement With Algorithme Pharma To Develop Multiplex Heparin Immunogenicity Assay 17
SQI Diagnostics Enters Into Distribution Agreement With Integrated Sciences 18
SQI Diagnostics Raises USD2.7 Million in Private Placement of Units 19
SQI Diagnostics Raises USD3.6 Million in Private Placement of Units 20
SQI Diagnostics Raises USD2.7 Million in Private Placement of Units 21
SQI Diagnostics Raises USD2.4 Million in Rights Offering of Shares 22
SQI Diagnostics Raises Additional Funds in Private Placement of Units 23
SQI Diagnostics Raises USD2.2 Million in Private Placement of Shares 24
SQI Diagnostics Raises USD2.2 Million in First Tranche of Private Placement of Shares 25
SQI Diagnostics Completes Public Offering Of Units For USD 3.8 Million 26
SQI Diagnostics Completes Private Placement Of Units For USD 1.3 Million 27
SQI Diagnostics Completes Private Placement Of Units For USD 4 Million 28
Sqi Diagnostics Completed Final Tranche Of Private Placement Of Units For Additional USD 0.5 Million 29
SQI Diagnostics Completes Second and Final Tranche of Private Placement of Debentures for USD1.3 Million 31
SQI Diagnostics Sells Sqid-X system to IRX Therapeutics 32
SQI Diagnostics Plans For Sale Of The Company 33
SQI Diagnostics Inc, Key Competitors 34
SQI Diagnostics Inc, Key Employees 35
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
SQI Diagnostics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
: +91 9015378249
Related Reports
Page 99 | 
April 2022
Page 47 | March 2022
Page 47 | February 2022
Page 91 | January 2022
Page 89 | December 2021